Rabies immune globulin
Showing 1 - 25 of >10,000
Survey of Human Rabies Immune Globulin Safety in Children
Recruiting
- Rabies
- +3 more
- Human rabies immune globulin 300 IU/mL
-
Houston, TexasHouston Methodist
Aug 22, 2022
Rabies Trial in Philippines, United States (SYN023, HRIG (HyperRab), Rabies vaccine)
Completed
- Rabies
- SYN023
- +2 more
-
Gainesville, Florida
- +13 more
Sep 29, 2022
Rabies (Healthy Volunteers) Trial in Gieres, Rennes Cedex (VRVg-2, Purified Inactivated Rabies Vaccine, Human Diploid Cell
Completed
- Rabies (Healthy Volunteers)
- VRVg-2
- +3 more
-
Gieres, France
- +1 more
Jun 28, 2022
Rabies Trial in Saint Paul (Active rabies vaccine (US-FDA approved))
Completed
- Rabies
- Active rabies vaccine (US-FDA approved)
-
Saint Paul, MinnesotaPrism Research Inc
Aug 31, 2021
Rabies, Communicable Disease, Virus Diseases Trial in Kunming (SYN023, HRIG, Rabies Vaccine)
Active, not recruiting
- Rabies
- +5 more
- SYN023
- +2 more
-
Kunming, ChinaYunnan Province Center for Disease Control and Prevention (CDC)
Sep 23, 2021
Rabies, Rabies Human, Rabies Virus Infection Trial in United States (Rabies PEP quality improvement bundle)
Completed
- Rabies
- +2 more
- Rabies PEP quality improvement bundle
-
Baytown, Texas
- +14 more
Aug 30, 2021
Rabies, Antibody Trial in Changchun (5 doses program)
Completed
- Rabies
- Antibody
- 5 doses program
-
Changchun, Jilin, ChinaChangchun Zhuoyi Biological Co., Ltd
Sep 18, 2022
Rabies Trial in Bangkok (rabies vaccine)
Recruiting
- Rabies
- rabies vaccine
-
Bangkok, ThailandQueen Saovabha Memorial Institute, Thai Red Cross Society
Apr 28, 2022
Rabies Trial in Bangkok (Equine rabies immunoglobulin injection on day 7)
Recruiting
- Rabies
- Equine rabies immunoglobulin injection on day 7
-
Bangkok, ThailandQueen Saovabha Memorial Institute, Thai Red Cross Society
Apr 28, 2022
Rabies Trial in Syracuse (Chloroquine, Atovaquone and Proguanil, Doxycycline)
Completed
- Rabies
- Chloroquine
- +3 more
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Apr 22, 2021
Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))
Withdrawn
- Chronic Hepatitis B
- hepatitis B immune globulin (HBIg)
- Pegylated interferon alfa (pegIFN)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 4, 2022
Rabies Trial in Ghent, Munich (RabipurĀ®, Rabies mRNA vaccine CV7202 Dose level 1, Rabies mRNA vaccine CV7202 Dose level 2)
Completed
- Rabies
- RabipurĀ®
- +3 more
-
Ghent, Belgium
- +1 more
Dec 22, 2021
Virus Diseases Trial in Austria, Germany, Switzerland (Rabipur, Blood sampling)
Active, not recruiting
- Virus Diseases
- Rabipur
- Blood sampling
-
Wien, Austria
- +6 more
Jan 3, 2022
Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%
Completed
- Primary Immunodeficiency Diseases (PID)
- Immune Globulin Intravenous (IGIV)
- Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
-
Nagoya-shi, Aichi, Japan
- +7 more
Feb 23, 2022
COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)
Not yet recruiting
- COPD Exacerbation Acute
- CUVITRU - Ig subcutaneous human 20%
- Standard Medical Therapy
-
Rochester, New York
- +2 more
Feb 28, 2023
Hepatitis A Trial in Almaty (Hepatitis A vaccine)
Completed
- Hepatitis A
- Hepatitis A vaccine
-
Almaty, KazakhstanSanitary EpidemiologyAuthority
Dec 27, 2021
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022
Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)
Recruiting
- Lung Transplant
- Hepatitis B
- Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
-
Philadelphia, PennsylvaniaHospital of University of Pennsylvania
Oct 1, 2022
Sickle Cell Disease, Pain Trial in Bronx (Immune Globulin Intravenous, Normal saline)
Recruiting
- Sickle Cell Disease
- Pain
- Immune Globulin Intravenous
- Normal saline
-
Bronx, New YorkMontefiore Medical Center
Jul 25, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- HYQVIA
- (no location specified)
Feb 23, 2023
Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))
Withdrawn
- Healthy
- Communicable Diseases
- Vaccinia Immune Globulin (Human)
- (no location specified)
Oct 28, 2021
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Primary Immune Deficiency Disorder Trial in United States (Bivigam, Other)
Active, not recruiting
- Primary Immune Deficiency Disorder
- Bivigam
- Other
-
Carpinteria, California
- +16 more
Jan 30, 2023